Fix formularies in US demands Mylan head
Changing payers’ formulary practices is crucial to ensuring that generic versions of complex drugs have a sustainable future in the US, according to Mylan’s chief executive officer, Heather Bresch.
Changing payers’ formulary practices is crucial to ensuring that generic versions of complex drugs have a sustainable future in the US, according to Mylan’s chief executive officer, Heather Bresch.